Conjugates based on nanostructured, superparamagnetic particles, at hermolabile linker andacytotoxic maytansinoidw ere developed to serve as am odel for tumour-selective drug delivery and release. It combines chemo-with thermal therapy. The linker-modified toxin was prepared by ac ombination of biotechnology and semisynthesis. Drug release was achieved by hyperthermiat hrough an external oscillating electromagnetic field that induces heat inside the particles. Efficacy of this releasec oncept was demonstrated both for cancerc ell proliferation in vitro, and for tumour growth in vivo, in ax enograft mousem odel. Biocompatibility studies for these magnetic-nanoparticle/ansamitocin conjugates complementthis work.